https://www.selleckchem.com/pr....oducts/gsk-2837808A.
Five-year overall survival (OS) was 59.4%. When the patients were divided into high-risk (HR) and low-risk (LR) groups based on the RC, 5-year OS was significantly less in the HR group (43.9%) than in the LR group (82.2%; P 0.05). The RC, which was developed primarily to determine perioperative risk, can predict long-term prognosis for compromised patients who undergo PS. The RC, which was developed primarily to determine perioperative risk, can predict long-term prognosis for compromised patients who undergo PS. Brain-dead do
Like
Comment
Share
